According to the latest Hong Kong Stock Exchange filings, Lazard Asset Management LLC acquired an additional 235,200 shares of SINOPHARM (01099) on October 2nd at a price of HK$18.61 per share, representing a total transaction value of approximately HK$4.3771 million. Following this acquisition, the investment firm now holds approximately 134 million shares, representing a 10.01% ownership stake in the company.